The 35% reduction in flow of apoB down the delipidation cascade will have predictable consequences for the products of lipolysis of VLDL1 — remnant VLDL particles and LDL — which are implicated as causal factors in atherosclerosis (25). This evidence concerns the gene APOB and atherosclerosis.